71 related articles for article (PubMed ID: 7909417)
21. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
[TBL] [Abstract][Full Text] [Related]
22. Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells.
Blagosklonny MV; Bishop PC; Robey R; Fojo T; Bates SE
Cancer Res; 2000 Jul; 60(13):3425-8. PubMed ID: 10910051
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxicity of paclitaxel in comparison with other anticancer agents against neoplastic cells obtained from clinical gastrointestinal carcinoma tissue.
Matsuoka H; Yano K; Saito T; Seo Y; Tomoda H
Anticancer Res; 1995; 15(5B):2001-6. PubMed ID: 8572592
[TBL] [Abstract][Full Text] [Related]
24. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.
Polizzi D; Pratesi G; Tortoreto M; Supino R; Riva A; Bombardelli E; Zunino F
Cancer Res; 1999 Mar; 59(5):1036-40. PubMed ID: 10070960
[TBL] [Abstract][Full Text] [Related]
25. [Effect of podophyllotoxin on human gastric cancer cell line SGC 7901].
Zhang J; Zhou CS; Liu S; Chen H; Yang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):718-22. PubMed ID: 18772512
[TBL] [Abstract][Full Text] [Related]
26. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Patil Y; Sadhukha T; Ma L; Panyam J
J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
[TBL] [Abstract][Full Text] [Related]
28. Antimicrotubular and cytotoxic activity of geiparvarin analogues, alone and in combination with paclitaxel.
Miglietta A; Bocca C; Gabriel L; Rampa A; Bisi A; Valenti P
Cell Biochem Funct; 2001 Sep; 19(3):181-9. PubMed ID: 11494307
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
30. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
Clin Cancer Res; 2000 Sep; 6(9):3621-8. PubMed ID: 10999754
[TBL] [Abstract][Full Text] [Related]
32. Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy.
Mårlind J; Kaspar M; Trachsel E; Sommavilla R; Hindle S; Bacci C; Giovannoni L; Neri D
Clin Cancer Res; 2008 Oct; 14(20):6515-24. PubMed ID: 18927291
[TBL] [Abstract][Full Text] [Related]
33. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.
Ueno NT; Yu D; Hung MC
Oncogene; 1997 Aug; 15(8):953-60. PubMed ID: 9285690
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.
Zhang L; Lau YK; Xia W; Hortobagyi GN; Hung MC
Clin Cancer Res; 1999 Feb; 5(2):343-53. PubMed ID: 10037184
[TBL] [Abstract][Full Text] [Related]
35. P-glycoprotein-independent apoptosis induction by a novel synthetic compound, MMPT [5-[(4-methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone].
Teraishi F; Wu S; Sasaki J; Zhang L; Zhu HB; Davis JJ; Fang B
J Pharmacol Exp Ther; 2005 Jul; 314(1):355-62. PubMed ID: 15831436
[TBL] [Abstract][Full Text] [Related]
36. STI571 as a potent inhibitor of growth and invasiveness of human epithelial breast cancer cells.
Roussidis AE; Mitropoulou TN; Theocharis AD; Kiamouris C; Papadopoulos S; Kletsas D; Karamanos NK
Anticancer Res; 2004; 24(3a):1445-7. PubMed ID: 15274308
[TBL] [Abstract][Full Text] [Related]
37. [DMSO induced differentiation of human gastric adenocarcinoma cell line MGC 80-3].
Yang SM
Shi Yan Sheng Wu Xue Bao; 1994 Sep; 27(3):281-7. PubMed ID: 7801721
[TBL] [Abstract][Full Text] [Related]
38. Growth and differentiation of human gastrointestinal adenocarcinoma stem cells in soft agarose.
Laboisse CL; Augeron C; Potet F
Cancer Res; 1981 Jan; 41(1):310-5. PubMed ID: 7448770
[TBL] [Abstract][Full Text] [Related]
39. [Characteristics of the cytostatic effects of oridonin in vitro].
Li XT; Lin C; Li PY
Zhongguo Yao Li Xue Bao; 1986 Jul; 7(4):361-3. PubMed ID: 2954401
[No Abstract] [Full Text] [Related]
40. [Comparative study on the sensitivities of seven human cancer cell lines to rubescensine A].
Li XT; Lin C; Li PY; Zhang TM
Yao Xue Xue Bao; 1985 Apr; 20(4):243-6. PubMed ID: 4072693
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
